- Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapyDeborah DeEugenio
Department of Pharmacy Practice, College of Pharmacy, Temple University, Philadelphia, Pennsylvania, USA
Pharmacotherapy 27:691-6. 2007..To characterize the safety of concomitant aspirin, clopidogrel, and warfarin therapy after percutaneous coronary intervention (PCI), and to identify patient characteristics that increase the risk of hemorrhage...
- Early-onset heparin-induced thrombocytopenia after a 165-day heparin-free interval: case report and review of the literatureDeborah L DeEugenio
Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, PA 19140, USA
Pharmacotherapy 25:615-9. 2005..If clinicians are compelled to reexpose patients to heparin, they should confirm a negative HIT assay result, monitor for clinical signs of HIT, and provide appropriate treatment if HIT is suspected...